CompoAtlas

Ester-C® with calcium, bioflavonoids, and Bioperine®

Natural health product licensed in Canada

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Vitamine C

Source : Ascorbate de calcium

600 mg1,200,000 µg
Piperine

Source : Fruit(s)

3 mgNot calculated
Piperine

Source : Piper nigrum

3 mgNot calculated
Bioflavonoïdes d'agrumes

Source : Citrus sinensis

Potency : 50 % Hesperidin

150 mgNot calculated
Bioflavonoïdes d'agrumes

Source : Fruit(s)

Potency : 50 % Hesperidin

150 mgNot calculated

Non-medicinal ingredients

Hydroxypropylméthylcellulose, Cellulose - microcrystalline, Dioxyde de silicium, Stéarate de magnésium

PopulationAgeQuantity per servingFrequency
AdultesNot specified2 Capsule1 Tous les jours

Uses authorised in Canada

For the maintenance of good health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Product record

Licence holder
Biomed International Products Corp.
NPN or DIN-HM
80003499
Status
Active licence
Licence date
28 May 2007
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

Source

Official Health Canada record, licence 80003499

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Piperine
    Read the warning, when it applies and the studies cited

    BLACK/WHITE PEPPER - PIPER NIGRUM

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications or any other health products, as black/white pepper/piperine may alter their effectiveness (Han 2011; Srinivasan 2007; Khajuria et al. 2002; Bano et al. 1991).1

    Sources cited by Health Canada (4)
    • Bano G, Raina RK, Zutshi U, Bedi KL, Johri RK, Sharma SC. Effect of piperine on bioavailability and pharmacokinetics of propranolol and theophylline in healthy volunteers. European Journal of Pharmacology 1991;41(6):615-7. PubMed
    • Han HK. The effects of black pepper on the intestinal absorption and hepatic metabolism of drugs. Expert Opinion on Drug Metabolism & Toxicology 2011;7(6):721-729. PubMed Review article
    • Khajuria A, Thusu N, Zutshi U. Piperine modulates permeability characteristics of intestine by inducing alterations in membrane dynamics: influence on brush border membrane fluidity, ultrastructure and enzyme kinetics. Phytomedicine 2002;9(3):224-31. PubMed
    • Srinivasan K. Black Pepper and its pungent principle-piperine: a review of diverse physiological effects. Critical Reviews in Food Science and Nutrition 2007;47(8):735-748. PubMed Review article

    1Note: At subtherapeutic quantities, the risk statement regarding the alteration of effectiveness is not required for products providing 25 mg or less Piper nigrum fruit per day for Class II and III applications.

    Condition of application: Improve digestion.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: Vermifuge/anthelmintic.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or persist for more than 2 weeks.

    Health Canada monograph dated 19 December 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Ester-C® with calcium, bioflavonoids, and Bioperine®”, https://compoatlas.com/en/supplements/canada/80003499-ester-c-with-calcium-bioflavonoids-and-bioperine, updated 28 May 2007.

Enter to analyse, Shift+Enter for a new line